SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Association of care specialty with anticoagulant prescription and clinical outcomes in newly diagnosed atrial fibrillation: Results from the GARFIELD-AF registry.

Camm, CF; Virdone, S; Jerjes-Sánchez, C; Oh, S; Eikelboom, JW; Oto, A; Fox, KAA; Camm, AJ; Pieper, KS; Goto, S; et al. Camm, CF; Virdone, S; Jerjes-Sánchez, C; Oh, S; Eikelboom, JW; Oto, A; Fox, KAA; Camm, AJ; Pieper, KS; Goto, S; Ragy, H; Kakkar, AK; GARFIELD-AF registry (2002) Association of care specialty with anticoagulant prescription and clinical outcomes in newly diagnosed atrial fibrillation: Results from the GARFIELD-AF registry. Int J Cardiol, 421. p. 132866. ISSN 1874-1754 https://doi.org/10.1016/j.ijcard.2024.132866
SGUL Authors: Camm, Alan John

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (2MB) | Preview
[img] Microsoft Word (.docx) (Supplementary material) Supplemental Material
Download (316kB)

Abstract

OBJECTIVE: To determine whether stroke prevention strategy, comorbidity management, and clinical outcome risks differ across atrial fibrillation (AF) care specialties. METHODS: Newly diagnosed non-valvular AF patients enrolled in the international, prospective GARFIELD-AF registry (enrolment: 2010-2016) were analysed. Prescription of oral anticoagulation (OAC) therapy and select comorbidities was assessed by baseline care specialty: cardiology, primary care, or other specialties (internist/neurologist/geriatrician). Associations between care specialty and 2-year clinical outcomes were evaluated using multivariable Cox frailty models to account for within-country homogeneity. RESULTS: In 52,011 patients, 34,172 (65.7 %) were diagnosed and initially managed in cardiology care, 7396 (14.2 %) in primary care, and 10,443 (20.1 %) in other specialties. The inter-country care specialty distribution varied considerably. Non-vitamin K OAC (NOAC) therapy among CHA2DS2-VASc ≥2 patients was more common in cardiology care (31.0 %) than primary care (19.8 %) and other specialty care (24.9 %), but comorbidity management was similar across specialties. Compared to cardiology care, primary care was associated with greater non-cardiovascular mortality (1.21 [1.01-1.45]), major bleeding (1.31 [1.05-1.62]), and new/worsening heart failure risk (2.09 [1.69-2.59]). Care in other specialties was associated with greater all-cause (adjusted hazard ratio, 1.19 [95 % CI, 1.09-1.29]), cardiovascular (1.15 [1.01-1.31]), and non-cardiovascular mortality (1.29 [1.13-1.47]), as well as non-haemorrhagic stroke/systemic embolism (1.48 [1.26-1.73]), major bleeding (1.21 [1.02-1.43]), and new/worsening heart failure risk (1.45 [1.21-1.75]) than cardiology care. CONCLUSION: Comorbidity management was similar across AF care specialties, but patients outside of cardiology care had fewer NOAC prescriptions and greater risk for most clinical endpoints. Cardiology expertise may have important implications for AF prognosis. CLINICAL TRIAL REGISTRATION: URL: http://www. CLINICALTRIALS: gov. Unique identifier for GARFIELD-AF: NCT01090362.

Item Type: Article
Additional Information: © 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Keywords: Atrial fibrillation, Care setting, Care specialty, Non-vitamin K oral anticoagulant, Outcomes, Vitamin K anticoagulant, GARFIELD-AF registry, Atrial fibrillation, Care specialty, Care setting, Outcomes, Non-vitamin K oral anticoagulant, Vitamin K anticoagulant, 1102 Cardiorespiratory Medicine and Haematology, 1117 Public Health and Health Services, Cardiovascular System & Hematology
SGUL Research Institute / Research Centre: Academic Structure > Cardiovascular & Genomics Research Institute
Academic Structure > Cardiovascular & Genomics Research Institute > Clinical Cardiology
Journal or Publication Title: Int J Cardiol
ISSN: 1874-1754
Language: eng
Dates:
DateEvent
15 February 2002Published
2 December 2024Published Online
27 November 2024Accepted
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDThrombosis Research InstituteUNSPECIFIED
PubMed ID: 39631531
Web of Science ID: WOS:001377879200001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/117058
Publisher's version: https://doi.org/10.1016/j.ijcard.2024.132866

Actions (login required)

Edit Item Edit Item